Adelene Q. Perkins, President & Chief Executive Officer at INFINITY PHARMACEUTICALS, INC. (INFI), sold 45,000 shares at $20.81 ($932K) on 2013-09-12, disclosed to the SEC on 2013-09-13.
Scheduled sale ($932k) by President & Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.81 | 31,924 | $664K | 71.3% |
| 2 | $20.50 | 13,076 | $268K | 28.7% |
| Total | $20.72 avg | 45,000 | $932K | 100% |
| Filing → |
| INFI | SELL | 2018-03-07 | $14K | — | Filing → |
| INFI | SELL | 2015-06-26 | $55K | — | Filing → |
| INFI | SELL | 2015-05-28 | $128K | — | Filing → |